EPIDEMIOLOGICAL DISTRIBUTION OF SOFT PART TUMORS IN A TERTIARY HOSPITAL
- PMID: 36451787
- PMCID: PMC9670784
- DOI: 10.1590/1413-785220223005e256403
EPIDEMIOLOGICAL DISTRIBUTION OF SOFT PART TUMORS IN A TERTIARY HOSPITAL
Abstract
Objective: To evaluate cases of soft tissue tumors at the Orthopedic Oncology service of the PUC-Campinas Hospital and determine the epidemiological profile in the period from February 2012 to November 2019, associating the participation of a non-reference hospital in the approach and treatment of the pathology.
Methods: This study evaluated 72 patients aged 18 to 81 years, of both sexes and diagnosed with soft tissue tumor and divided into two groups: (I) primary etiology and (II) metastatic etiology.
Results: Of 146 patients admitted, 22 resulted in deaths, with 9 patients from Group I, and 13 from Group II. For all patients with soft tissue tumor, aged between 51 and 58 years, admitted in the period, the probability of survival after 46 months was 71.84%, Group I's was 22.7% and Group II's 91.43%.
Conclusion: Despite the scarcity of epidemiological data related to soft tissue tumor, the data appreciated in the hospital's service, not a reference in treating this type of condition, are compatible with the data presented in specialized hospitals in Brazil, thus, in confluence with the literature. Level of Evidence III, Comparative, Prognostic and Retrospective Study.
Objetivo: Avaliar casos de tumores de partes moles do Serviço de Oncologia Ortopédica do Hospital PUC-Campinas e determinar o perfil epidemiológico no período de fevereiro de 2012 a novembro de 2019, associando à participação de um hospital que não é referência na abordagem e tratamento da patologia.
Métodos: Foi realizada uma análise exploratória de dados com 72 pacientes entre 18 e 81 anos, de ambos os sexos e com diagnóstico de tumor de partes moles. Eles foram avaliados e divididos em dois grupos: (I) de etiologia primária e (II) de etiologia metastática.
Resultados: Do total de 146 pacientes admitidos, 22 vieram a óbito, sendo 9 pacientes do Grupo I, e 13 do Grupo II. Para todos os pacientes com tumor de partes moles, com idade entre 51 e 58 anos, admitidos no período, a probabilidade de sobrevida após 46 meses foi de 71,84%, enquanto do Grupo I foi de 22,7%, e do Grupo II foi de 91,43%.
Conclusão: Apesar da escassez de dados epidemiológicos relacionados ao tumor de partes moles, os dados apreciados no serviço do hospital, que não é referência no tratamento dessa condição, são compatíveis com os dados apresentados em hospitais especializados no Brasil, assim, corroborando a literatura. Nível de Evidência III, Estudo Retrospectivo Comparativo Prognóstico.
Keywords: Epidemiology; Neoplasms; Sarcoma; Soft Tissue Neoplasms.
Conflict of interest statement
All authors declare no potential conflict of interest related to this article.
Similar articles
-
Distribution and evaluation of bone and soft tissue tumors operated in a tertiary care center.Acta Orthop Traumatol Turc. 2019 May;53(3):189-194. doi: 10.1016/j.aott.2019.03.008. Epub 2019 Apr 11. Acta Orthop Traumatol Turc. 2019. PMID: 30982757 Free PMC article.
-
Neglected orthopedic oncology--Causes, epidemiology and challenges for management in developing countries.Indian J Cancer. 2015 Jul-Sep;52(3):325-9. doi: 10.4103/0019-509X.176737. Indian J Cancer. 2015. PMID: 26905128
-
[Analysis of clinicopathological characteristics and prognostic factors of foot and ankle soft tissue and bone tumors].Zhonghua Zhong Liu Za Zhi. 2018 Sep 23;40(9):685-689. doi: 10.3760/cma.j.issn.0253-3766.2018.09.010. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30293395 Chinese.
-
[Two cases with metastatic intracerebral alveolar soft part sarcoma].No Shinkei Geka. 1995 Jul;23(7):627-32. No Shinkei Geka. 1995. PMID: 7637847 Review. Japanese.
-
Prognostic factors in soft tissue sarcoma.Acta Orthop Scand Suppl. 1997 Feb;273:148-55. doi: 10.1080/17453674.1997.11744722. Acta Orthop Scand Suppl. 1997. PMID: 9057607 Review.
Cited by
-
The Predictive Role of the Histopathological Scoring System in Adipose Tumors-Lipoma, Atypical Lipomatous Tumor, and Liposarcoma.Diagnostics (Basel). 2023 Dec 5;13(24):3606. doi: 10.3390/diagnostics13243606. Diagnostics (Basel). 2023. PMID: 38132190 Free PMC article.
-
Gut Microbiota's role in lipoma development: evidence from mendelian randomization.Front Genet. 2024 Nov 15;15:1430671. doi: 10.3389/fgene.2024.1430671. eCollection 2024. Front Genet. 2024. PMID: 39619672 Free PMC article.
References
-
- Instituto Nacional de Câncer José Alencar Gomes da Silva . Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: Inca; 2019.
-
- Manoel WJ, Sarmento BJ, Silveira LP, Jr, Abreu DC, Abreu IP, Neto, Ferreira EC. Sarcomas de alto grau estudo retrospectivo de 131 casos. Rev Col Bras Cir. 2008;35(2):83–87.
-
- Silva EO. Sarcomas de partes moles de extremidades: análise da sobrevida, funcionalidade e qualidade de vida no Rio de Janeiro. Rio de Janeiro: Fundação Oswaldo Cruz; 2011. master's.
-
- Rajput A, Kraybill WG. Clinical trials and soft tissue sarcomas. Surg Oncol Clin N Am. 2003;12(2):485–497. - PubMed
-
- Sobin LH, Wittekind C. TNM classification of malignant tumors. 6. New York: Wiley-Liss; 2002.
LinkOut - more resources
Full Text Sources